| Company Name: |
BioBioPha Co., Ltd.
|
| Tel: |
0871-65217109 13211707573; |
| Email: |
y.liu@mail.biobiopha.com |
| Products Intro: |
Product Name:Broussonin E
CAS:90902-21-9
Purity:96.0% Package:5mg Remarks:BBP02199
|
Broussonin E manufacturers
- Broussonin E
-
- $61.00
-
2026-06-04
- CAS:90902-21-9
- Purity:
- Supply Ability: 10g
|
| | Broussonin E Basic information |
| Product Name: | Broussonin E | | Synonyms: | Broussonin E;2-[3-(3-Hydroxy-4-methoxyphenyl)propyl]-5-methoxyphenol;Phenol,2-[3-(3-hydroxy-4-methoxyphenyl)- propyl]-5-methoxy- | | CAS: | 90902-21-9 | | MF: | C17H20O4 | | MW: | 288.34 | | EINECS: | | | Product Categories: | | | Mol File: | 90902-21-9.mol |  |
| | Broussonin E Chemical Properties |
| solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | form | Powder | | color | White to off-white |
| | Broussonin E Usage And Synthesis |
| Description | Broussonin E could suppress inflammation by modulating macrophages activation state via inhibiting the ERK and p38 MAPK and enhancing JAK2-STAT3 signaling pathway, and can be further developed as a promising drug for the treatment of inflammation-related diseases such as atherosclerosis. | | Uses | Broussonin E is a phenolic compound and shows anti-inflammatory activity. Broussonin E can suppress inflammation by modulating macrophages activation statevia inhibiting the ERK and p38 MAPK and enhancing JAK2-STAT3 signaling pathway. Broussonin E can be used for the research of inflammation-related diseases such as atherosclerosis[1]. | | target | TNF-α | p38 MAPK | ERK | JAK | STAT | | IC 50 | ERK; p38 MAPK; JAK2; STAT3; IL-1β; IL-6; COX-2; IL-10 | | References | [1] Huang SP, et al. Broussonin E suppresses LPS-induced inflammatory response in macrophages via inhibiting MAPK pathway and enhancing JAK2-STAT3 pathway. Chin J Nat Med. 2019 May 20;17(5):372-380. DOI:10.1016/S1875-5364(19)30043-3 |
| | Broussonin E Preparation Products And Raw materials |
|